Background
Methods
Study design
Study setting and population
Pseudo-lockdown measures description
Participants’ characteristics
Statistical analysis
Results
Period | Population ≥ 16 y.o.a | PRI type A, B and Cb | PRI type B and Cb | ||||||
---|---|---|---|---|---|---|---|---|---|
Full year | Mar 16-Jun 19 | Full year | Mar 16-Jun 19 | ||||||
N | Incidence | N | Incidence | N | Incidence | N | Incidence | ||
2014 | 403′045 | 18 | 4.5 | 5 | 1.2 | 14 | 3.5 | 4 | 1.0 |
2015 | 409′722 | 21 | 5.1 | 6 | 1.5 | 16 | 3.9 | 4 | 1.0 |
2016 | 412′429 | 20 | 4.8 | 7 | 1.7 | 17 | 4.1 | 7 | 1.7 |
2017 | 416′254 | 32 | 7.7 | 9 | 2.2 | 26 | 6.2 | 8 | 1.9 |
2018 | 419′288 | 18 | 4.3 | 6 | 1.4 | 14 | 3.3 | 5 | 1.2 |
2019 | 423′172 | 19 | 4.5 | 10 | 2.4 | 17 | 4.0 | 10 | 2.4 |
2020 | 424′901 | 16 | 3.8 | 6 | 1.4 | 14 | 3.3 | 6 | 1.4 |
Period | ISS (median, IQR1-3) | HD instability rate (%) and PRBC/24 h [median (IQR1-3)] | Death rate (%) and timing [in days: median (IQR1-3)] | ICU rate (%) and LOS [in days: median (IQR1-3)] | Hospital LOS [in days: median (IQR1-3)] | |||||
---|---|---|---|---|---|---|---|---|---|---|
Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | |
2014 | 26 (18.5–29) | 31.5 (24–38) | 14%; 5 (4–8) | 25%; 20.5 (10.8–30.2) | 14%; 11 (6–16) | 25%; 1 (1–1) | 50%; 12 (6.5–15.5) | 25%; 22 (22–22) | 16.5 (9–20.8) | 10 (4.8–24) |
2015 | 20.5 (16.8–27.2) | 18.5 (15.2–22) | 19%; 3 (2–4.8) | 0%; - | 0%; - | 0%; - | 50%; 7 (3.5–11.5) | 0%; - | 18.5 (11.8–29.5) | 9 (7–11.5) |
2016 | 29 (22–38) | 24 (20–32.5) | 24%; 5 (3.5–7.5) | 29%; 4 (3.5–6.5) | 24%; 17 (11.8–27) | 29%; 26.5 (14.2–38.8) | 71%; 6.5 (2–9.8) | 71%; 2 (2–5) | 15 (7–27) | 20 (9–39) |
2017 | 22 (17.2–40.2) | 30.5 (21.5–35.8) | 35%; 7 (4–10) | 50%; 8.5 (6.2–10) | 12%; 1 (1–26.5) | 13%; 1 (1–1) | 42%; 11 (8–25.5) | 63%; 16 (7.8–24.5) | 19 (11–52) | 27 (8.5–65) |
2018 | 29 (19.8–34) | 24 (19–29) | 21%; 2 (2–2) | 20%; 2 (2–2) | 14%; 4.5 (2.8–6.2) | 0%; - | 57%; 10.5 (3.5–17.5) | 60%; 11 (11–24) | 19 (13–23.8) | 24 (21–75) |
2019 | 22 (13–27) | 21 (14–26.2) | 35%; 12.5 (11.2–13.8) | 20%; 15 (15–15) | 12%; 5 (3–7) | 10%; 9 (9–9) | 35%; 1.5 (1–8.8) | 50%; 1 (1–2) | 35 (26–57) | 32 (18.5–43.8) |
2020 | 22.5 (18.2–32.8) | 27 (11.8–39.2) | 29%; 1.5 (1–5.2) | 33%; 1.5 (1.2–1.8) | 0%; - | 0%; - | 29%; 7 (6–13) | 50%; 7 (5–7) | 13 (9–19.2) | 14 (10.2–14) |
Period | ISS ≥ 16 | ISS ≥ 20 | ISS ≥ 24 | |||
---|---|---|---|---|---|---|
Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | |
2014 | 127 | 22 | 91 | 18 | 76 | 16 |
2015 | 109 | 20 | 77 | 15 | 60 | 13 |
2016 | 141 | 42 | 101 | 32 | 77 | 23 |
2017 | 151 | 33 | 84 | 24 | 69 | 19 |
2018 | 146 | 39 | 81 | 21 | 60 | 19 |
2019 | 138 | 37 | 90 | 22 | 66 | 15 |
2020 | 129 | 34 | 73 | 15 | 57 | 11 |
Period | Suicide as a cause of polytrauma (%) | ISS (median, IQR1-3) | Death rate (%) and timing [in days: median (IQR1-3)] | ICU rate (%) and LOS [in days: median (IQR1-3)] | Hospital LOS (in days: median (IQR1-3)) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Full year (%) | Mar 16–Jun 19 (%) | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | |
2014 | 9 | 5 | 25 (18.5–29) | 25.5 (22.8–29) | 18%; 1 (1–5) | 15%; 1.5 (1–2.8) | 76%; 6 (2–13) | 56%; 6.5 (2–15.8) | 15 (7–25.5) | 11.5 (1.2–20.2) |
2015 | 10 | 15 | 25 (18–29) | 25 (20.2–29) | 12%; 1 (1–3) | 15%; 1 (1–2) | 75%; 4 (2–9) | 57%; 2.5 (2–5.5) | 13 (6–23) | 9 (3–14.8) |
2016 | 6 | 2 | 25 (18–29) | 24 (20–25) | 18%; 2 (2–5) | 15%; 2 (1–4.2) | 59%; 3 (2–7.5) | 56%; 2 (2–5) | 11 (4–21) | 10 (2–19.8) |
2017 | 8 | 12 | 22 (17–27) | 25 (19–34) | 15%; 2 (1–10.5) | 15%; 1 (1–3) | 56%; 5 (2–9) | 57%; 6 (2–7.5) | 12 (4–21) | 12 (3–20) |
2018 | 6 | 8 | 21 (17–28.5) | 22 (17–28) | 14%; 2 (1–6) | 15%; 2 (1–3) | 44%; 5 (2.8–9.2) | 56%; 6 (4–8) | 12 (5.2–20) | 14 (6–23) |
2019 | 7 | 5 | 22 (18–26) | 22 (17–25) | 16%; 3.5 (2–5.8) | 15%; 4 (2.8–6.2) | 45%; 4.5 (3–8) | 56%; 4 (3–7) | 12 (5.2–20) | 9 (5–18) |
2020 | 4 | 0 | 22 (17–26) | 19 (17–26) | 11%; 4.5 (2.2–25) | 15%; 4 (1.8–12.2) | 31%; 7 (3–11) | 55%; 5 (3–7) | 10 (4–17) | 9 (4–14) |